Novabridge Biosciences ADR
(NBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 4,309 | 0 | 0 | 0 | 0 |
| Gross Profit | 4,309 | N/A | N/A | N/A | N/A |
| Operating Expenses | 214,739 | 0 | 0 | 0 | 0 |
| Operating Income | -210,430 | N/A | N/A | N/A | N/A |
| Interest Expense | 430 | 0 | 0 | 0 | 0 |
| Other Income | 2,300 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -208,560 | 0 | 0 | 0 | 0 |
| Net Income Continuous | -208,560 | N/A | N/A | N/A | N/A |
| Net Income | $-208,560 | $N/A | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -66.47 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -64.99 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -66.47 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -64.99 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -28.90 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-208,184 | $N/A | $N/A | $N/A | $N/A |